Jazz Pharmaceuticals PLC

Q2 2019 13F Holders

CUSIP
00B4Q5ZN4
Type
Equity
Class
COMMON
Num filings
3
Total reported value, excl. options
$6.51 M
Manager Report Date Value ($000) Shares Option Type